Anti-SEM3B/ SEMA3B/ LUCA-1 functional antibody

Anti-SEM3B/ SEMA3B/ LUCA-1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SEMA3B/SEMA3B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0459-Ab-1/ GM-Tg-hg-SE0459-Ab-2Anti-Human SEMA3B monoclonal antibodyHuman
GM-Tg-rg-SE0459-Ab-1/ GM-Tg-rg-SE0459-Ab-2Anti-Rat SEMA3B monoclonal antibodyRat
GM-Tg-mg-SE0459-Ab-1/ GM-Tg-mg-SE0459-Ab-2Anti-Mouse SEMA3B monoclonal antibodyMouse
GM-Tg-cynog-SE0459-Ab-1/ GM-Tg-cynog-SE0459-Ab-2Anti-Cynomolgus/ Rhesus macaque SEMA3B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0459-Ab-1/ GM-Tg-felg-SE0459-Ab-2Anti-Feline SEMA3B monoclonal antibodyFeline
GM-Tg-cang-SE0459-Ab-1/ GM-Tg-cang-SE0459-Ab-2Anti-Canine SEMA3B monoclonal antibodyCanine
GM-Tg-bovg-SE0459-Ab-1/ GM-Tg-bovg-SE0459-Ab-2Anti-Bovine SEMA3B monoclonal antibodyBovine
GM-Tg-equg-SE0459-Ab-1/ GM-Tg-equg-SE0459-Ab-2Anti-Equine SEMA3B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0459-Ab-1/ GM-Tg-hg-SE0459-Ab-2; GM-Tg-rg-SE0459-Ab-1/ GM-Tg-rg-SE0459-Ab-2;
GM-Tg-mg-SE0459-Ab-1/ GM-Tg-mg-SE0459-Ab-2; GM-Tg-cynog-SE0459-Ab-1/ GM-Tg-cynog-SE0459-Ab-2;
GM-Tg-felg-SE0459-Ab-1/ GM-Tg-felg-SE0459-Ab-2; GM-Tg-cang-SE0459-Ab-1/ GM-Tg-cang-SE0459-Ab-2;
GM-Tg-bovg-SE0459-Ab-1/ GM-Tg-bovg-SE0459-Ab-2; GM-Tg-equg-SE0459-Ab-1/ GM-Tg-equg-SE0459-Ab-2
Products NameAnti-SEMA3B monoclonal antibody
Formatmab
Target NameSEMA3B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SEMA3B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0459-Ag-1Recombinant multi-species SEM3B/ SEMA3B/ LUCA-1 protein


    Target information

    Target IDGM-SE0459
    Target NameSEMA3B
    Gene ID7869,20347,363142,703553,484762,101092422,539996,100062048
    Gene Symbol and SynonymsLUCA-1,SemA,SEMA3B,SEMA5,SEMAA,semaV
    Uniprot AccessionQ13214
    Uniprot Entry NameSEM3B_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000012171
    Target ClassificationTumor-associated antigen (TAA)

    The target: SEMA3B, gene name: SEMA3B, also named as LUCA-1, SEMA5, SEMAA, SemA, semaV. The protein encoded by this gene belongs to the class-3 semaphorin/collapsin family, whose members function in growth cone guidance during neuronal development. This family member inhibits axonal extension and has been shown to act as a tumor suppressor by inducing apoptosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.